Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators.

Abstract excerpt

Cystic fibrosis is a severe autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene encoding the CFTR protein, a chloride channel expressed in many epithelial cells. New drugs called CFTR modulators aim at restoring the CFTR protein function, and they will benefit many patients with cystic fibrosis in the near future. However, some patients bear rare...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell- and Tissue-Based Therapy
• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Research Advances